Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS

US Patent 7037644 · Granted May 2, 2006

Estimated economic value: $2,337,000

Assignee

Inventors

View full patent text on Google Patents →